Genmont Biotech Inc.

Wee-wei Chieng

Wan-Hua Tsai

Wen-Ling Yeh

Ming-Shiou Jan

Li-Jin Hsu

Ying-Chun Lai

I-ling Hsu

Shan-ju Hsu

A probiotic composition for improving an effect of a chemotherapeutic drug of Gemcitabine on inhibiting pancreatic cancer is disclosed in the present disclosure. The probiotic composition comprises an effective amount ofGMNL-133, an effective amount ofGMNL-89, and a pharmaceutically acceptable carrier, wherein theGMNL-133 was deposited in the China Center for Type Culture Collection on Sep. 26, 2011 under an accession number CCTCC NO. M 2011331, and theGMNL-89 was deposited in the China Center for Type Culture Collection on Nov. 19, 2007 under an accession number CCTCC NO. M 207154. A method for improving the effect of the chemotherapeutic drug of Gemcitabine on inhibiting pancreatic cancer is further disclosed in the present disclosure.

Method for improving an effect of chemotherapeutic drug of gemcitabine on inhibiting pancreatic cancer and improving side effect of chemotherapeutic drug of Gemcitabine

Growing community of inventors

Tainan, Taiwan

Wee-wei Chieng